Article Versions Notes

van der Burg SJC, van der Hiel B, Heimans L, Kerst JM, Wouters MWJM, Snaebjornsson P, Schrage YM, van der Graaf WTA, van Houdt WJ. The Role of [¹⁸F]FDG PET/CT Prior to and During Neoadjuvant Chemotherapy for Soft Tissue Sarcomas. Current Oncology. 2025; 32(5):257. https://doi.org/10.3390/curroncol32050257

van der Burg, Stijn J.C., Bernies van der Hiel, Lotte Heimans, J. Martijn Kerst, Michel W.J.M. Wouters, Petur Snaebjornsson, Yvonne M. Schrage, Winette T.A. van der Graaf, and Winan J. van Houdt. 2025. "The Role of [¹⁸F]FDG PET/CT Prior to and During Neoadjuvant Chemotherapy for Soft Tissue Sarcomas" Current Oncology 32, no. 5: 257. https://doi.org/10.3390/curroncol32050257

van der Burg, S. J. C., van der Hiel, B., Heimans, L., Kerst, J. M., Wouters, M. W. J. M., Snaebjornsson, P., Schrage, Y. M., van der Graaf, W. T. A., & van Houdt, W. J. (2025). The Role of [¹⁸F]FDG PET/CT Prior to and During Neoadjuvant Chemotherapy for Soft Tissue Sarcomas. Current Oncology, 32(5), 257. https://doi.org/10.3390/curroncol32050257